Impact of immune checkpoint inhibition on ovarian reserve
The Oncologist · 05.02.2026 · 31 (3)
DOI: 10.1093/oncolo/oyag048 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Oncologist, online erschienen am 28.02.2026. Verfasst von Elizabeth I Buchbinder und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA. Hauptthemen laut MEDLINE: Ovarian Reserve, Immune Checkpoint Inhibitors, Melanoma. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 3 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Immune checkpoint inhibition (ICI) has become a mainstay of therapy for various types of malignancy and is being used earlier in the course of therapy. In addition, there are many young women diagnosed with cancers for whom ICI is the standard of care. However, the impact of ICI on fertility is unknown and hard to assess. To evaluate this, we performed an analysis of hormones associated with ovarian reserve in young women with melanoma treated with ipilimumab. Our study showed a reduction in anti-Mullerian hormone, a marker of ovarian reserve, in patients with melanoma treated with either ICI or targeted therapy. These results support the need for further work in this area to better understand the impact these therapies have on fertility.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.
- Division of Biostatistics, Department of Data Science, Dana-Farber Cancer Institute, Boston, MA 02215, USA.
- Department of Obstetrics/Gynecology, Brigham and Women's Hospital, Boston, MA 02215, USA.
- Department of Medical Oncology, Moffitt Cancer Center, Tampa, FL 33612, USA.
- Department of Gastroenterology, Massachusetts General Hospital, Boston, MA 02114, USA.
ORCID-Profile: Elizabeth I Buchbinder
Zitieren
APA
Buchbinder, E. I., Song, Z., Cohen, J. V., Lee, S. J., Smith, K. K., Manos, M., Tarhini, A., & Dougan, M. (2026). Impact of immune checkpoint inhibition on ovarian reserve. The Oncologist, 31(3). https://doi.org/10.1093/oncolo/oyag048
Vancouver
Buchbinder EI, Song Z, Cohen JV, Lee SJ, Smith KK, Manos M, et al. Impact of immune checkpoint inhibition on ovarian reserve. The Oncologist. 2026;31(3). doi:10.1093/oncolo/oyag048
BibTeX
@article{Buchbinder2026,
author = {Buchbinder, Elizabeth I and Song, Zihe and Cohen, Justine V and Lee, Sandra J and Smith, Kimberly K and Manos, Michael and Tarhini, Ahmad and Dougan, Michael},
title = {Impact of immune checkpoint inhibition on ovarian reserve},
journal = {The Oncologist},
year = {2026},
volume = {31},
number = {3},
doi = {10.1093/oncolo/oyag048}
}
EUVIMED